Nuevolution AB (publ) operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nuevolution AB (publ) with three other
pharmaceutical manufacturers in Europe:
of the United Kingdom
sales of £3.13 million [US$4.37 million]
of which 38%
Bonesupport Holding AB
(129.30 million Swedish Kronor [US$15.80 million]
Erytech Pharma SA
based in France
(3.36 million Euro [US$4.16 million]
Sales increased substantially in 2017:
During the year ended June of 2017, sales at
Nuevolution AB (publ) were SEK 120.32 million (US$14.70 million).
increase of 464.5%
versus 2016, when the company's sales were SEK 21.31 million.